Trial intelligence / Profile preview

PDA Study: Delayed antibiotic prescribing strategies in uncomplicated acute respiratory infections in primary care

2009-011159-29Phase 4Completed

Sponsor
Hospital de la Santa Creu i Sant Pau Research Institute
Start
Mar 2009
Modality
Small Molecules, Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of phenoxymethylpenicillin, josamycin and levofloxacin in acute respiratory illness (ARI) (3 arms), sponsored by Hospital de la Santa Creu i Sant Pau Research Institute. Primary endpoints: Duration of symptoms and Severity of symptoms. Started Mar 2009; status: completed.

02

Drugs

phenoxymethylpenicillinjosamycinlevofloxacin
03

Conditions

acute respiratory illness (ARI)

Beyond the preview

Go deeper on 2009-011159-29.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-011159-29.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call